Article
Multidisciplinary Sciences
Xiaqing Yu, Wen Jiang, Russell Oliver Kosik, Yingchun Song, Qiong Luo, Tingting Qiao, Junyu Tong, Simin Liu, Chengwen Deng, Shanshan Qin, Zhongwei Lv, Dan Li
Summary: The study found that patients with thyroid carcinoma show significant changes in gut microbiota compared to healthy controls, with 70% of patients having increased levels of Proteobacteria-types. Microbiota analysis can distinguish thyroid carcinoma patients from healthy controls.
JOURNAL OF ADVANCED RESEARCH
(2022)
Article
Oncology
Hafiz Muhammad Ishaq, Imran Shair Mohammad, Riaz Hussain, Rashida Parveen, Jafir Hussain Shirazi, Yang Fan, Muhammad Shahzad, Khezar Hayat, Huan Li, Ayesha Ihsan, Kiran Sher Muhammad, Muhammad Usman, Siruo Zhang, Lu Yuan, Shakir Ullah, Ana Claudia Paiva-Santos, Jiru Xu
Summary: This study investigated the changes in gut bacterial composition in thyroid cancer patients and found significant dysbiosis in the gut microbiota of euthyroid thyroid cancer patients. The results suggest that this study may propose new approaches to understanding the disease pathways, mechanisms, and treatment of thyroid cancer patients.
Review
Food Science & Technology
Kun Yao, Xiaodong Wei, Haijun Wang, Xiazi Nie, Dai Qiang
Summary: This review comprehensively discusses the factors affecting thyroid gland function, types, risk factors, and symptoms of thyroid cancer. Lifestyle factors and pollutants can increase thyroid-stimulating hormone levels, thereby increasing the prevalence of thyroid cancer. The role of oral and gut microbiota as well as the application of probiotics in thyroid cancer are also discussed.
FOOD SCIENCE & NUTRITION
(2023)
Article
Entomology
Geng Chen, Qianwen Li, Xiaowei Yang, Yunhe Li, Wenwen Liu, Fajun Chen, Lanzhi Han
Summary: This study investigates the influence of gut microbiota on the development of insect resistance to Bacillus thuringiensis (Bt) toxin in Chilo suppressalis. The results show that Bt-resistant strains have higher gut microbiota diversity and different composition compared to Bt-susceptible strains. The cooccurrence patterns of gut microbiota are more complex in Bt-resistant strains. Furthermore, larval mortality after exposure to Bt toxin is significantly reduced when gut bacteria are removed by antibiotics. These findings suggest the importance of gut microbiota in regulating Bt-induced killing mechanism and the potential impact of Bt selective pressure on microbiome composition and insect resistance.
JOURNAL OF PEST SCIENCE
(2023)
Article
Immunology
Ang Li, Tiantian Li, Xinxin Gao, Hang Yan, Jingfeng Chen, Meng Huang, Lin Wang, Detao Yin, Hongqiang Li, Runsheng Ma, Qiang Zeng, Suying Ding
Summary: This study found that patients with high-grade thyroid nodules have a decreased number of gut microbial species and gene families, as well as significant alterations in overall microbial composition. Additionally, the gut microbiome in participants with high-grade thyroid nodules is characterized by greater amino acid degradation and lower butyrate production. These findings highlight the potential of specific gut microbiota as a therapeutic target for regulating thyroid metabolism.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
(2021)
Article
Biology
Dongxue Huo, Chaoping Cen, Haibo Chang, Qianying Ou, Shuaiming Jiang, Yonggui Pan, Kaining Chen, Jiachao Zhang
Summary: A 6-month study conducted by Huo et al in patients with Graves' Disease showed that the combination of probiotic Bifidobacterium longum with methimazole potentially improves thyroid function and regulates TRAb concentration through the gut-thyroid axis.
COMMUNICATIONS BIOLOGY
(2021)
Article
Endocrinology & Metabolism
Camilla Virili, Ilaria Stramazzo, Marco Centanni
Summary: The intestinal microbiota has a pleiotropic effect on the intestinal barrier, nutrients metabolism, and immune system development and functions. Recent evidence suggests a possible role of altered gut microbiota composition in the pathogenesis and progression of several autoimmune disorders, including thyroid autoimmune diseases.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
(2021)
Article
Endocrinology & Metabolism
Baiqiang Lin, Fuya Zhao, Yang Liu, Xin Wu, Jing Feng, Xiangren Jin, Wei Yan, Xiao Guo, Shang Shi, Zhiyong Li, Lujia Liu, Hongye Chen, Haoran Wang, Shuang Wang, Yu Lu, Yunwei Wei
Summary: This study aimed to evaluate the effect of probiotics on thyroid hormone withdrawal (THW)-related complications in thyroid cancer patients and investigate their association with the oral-gut microbiota. The results showed that probiotics alleviated complications and restored microbial diversity. These complications were related to specific microbial communities.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Article
Medicine, General & Internal
Wanting Li, Feng Cheng, Jun Zhang, Caihong Li, Daijing Yu, Halimureti Simayijiang, Haiyan Liu, Sijin Li, Jiangwei Yan
Summary: This study investigated the changes in gut microbiota and metabolites following radioactive iodine therapy. It was found that the therapy led to a disturbance in the gut microbiota, with increased levels of Escherichia-Shigella. Some metabolites and functional pathways may have a positive effect on intestinal homeostasis.
INTERNATIONAL JOURNAL OF GENERAL MEDICINE
(2023)
Review
Biotechnology & Applied Microbiology
Stefano Bibbo, Serena Porcari, Livio Enrico Del Vecchio, Andrea Severino, Benjamin H. Mullish, Gianluca Ianiro, Antonio Gasbarrini, Giovanni Cammarota
Summary: The gut microbiome plays a crucial role in cancer development and treatment. Modulating the gut microbiome has shown to enhance the response to immune checkpoint inhibitors, especially in the treatment of renal cancer.
HUMAN VACCINES & IMMUNOTHERAPEUTICS
(2023)
Review
Biochemistry & Molecular Biology
Sally Temraz, Farah Nassar, Firas Kreidieh, Deborah Mukherji, Ali Shamseddine, Rihab Nasr
Summary: Disruptions in the human gut microbiome may be associated with a cycle of hepatocyte injury and regeneration characteristic of chronic liver disease, and can promote the development of hepatocellular carcinoma by inducing genetic and epigenetic changes. The gut microbiome affects host metabolism and immune response, potentially influencing the efficacy of immunotherapy and chemotherapy for liver cancer.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2021)
Review
Oncology
Qi Liu, Wei Sun, Hao Zhang
Summary: This review discusses the interaction between gut microbiota and thyroid diseases, including thyroid cancer, and the influence of metabolites produced by dysbiosis of the gut microbiota on hormone levels and susceptibility to thyroid cancer. The study also explores potential clinical applications of gut microbiota markers for the prevention and treatment of thyroid diseases, aiming to establish a better management strategy based on individualized treatment in relation to gut microbiota composition and pathological characteristics.
Review
Endocrinology & Metabolism
Wen Jiang, Ganghua Lu, Dingwei Gao, Zhongwei Lv, Dan Li
Summary: Emerging studies have provided initial understanding of the thyroid-gut axis, but more research is needed to elucidate the specific relationships and mechanisms between gut microbiota and thyroid.
FRONTIERS IN ENDOCRINOLOGY
(2022)
Review
Microbiology
Jinghang Xu, Qiao Zhan, Yanan Fan, Emily Kwun Kwan Lo, Fangfei Zhang, Yanyan Yu, Hani El-Nezami, Zheng Zeng
Summary: Liver cancer, especially hepatocellular carcinoma (HCC), is the third leading cause of cancer-related deaths globally. The emerging importance of gut homeostasis in HCC pathogenesis, patterns of dysbiosis in HCC patients, and potential role in diagnosis highlight the potential for improving treatment and prevention. Although clinical studies are lacking, animal models suggest that modulation of gut microbiota by probiotics could be a new approach to treat or prevent HCC development.
Review
Immunology
Jian-wei Yang, Shun Wan, Kun-peng Li, Si-Yu Chen, Li Yang
Summary: Mounting evidence suggests that both gut and urinary microbiota play significant roles in the development and treatment of renal cell carcinoma (RCC). Dysbiosis and potential mechanisms have been identified for gut microbiota involvement in RCC, while the presence of urinary microbiota challenges the traditional belief of urine sterility and its potential role in RCC development has been implicated as well. Additionally, the composition of gut microbiota may serve as a predictive marker for the efficacy of immune checkpoint inhibitors, and modulating microbiota may enhance the therapeutic effects of drugs for RCC.
FRONTIERS IN IMMUNOLOGY
(2023)